October 26, 2015 — OrbusNeich announced the presentation of the one-year clinical outcomes from the 1,000-patient REMEDE ...
Stents
This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents.
October 26, 2015 — Medinol announced in September the completion of enrollment in its BIONICS trial to evaluate the ...
October 23, 2015 — Results of the TUXEDO trial, designed to compare two types of stents in diabetic patients, found ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
October 22, 2015 — Results from the LEADERS FREE trial found that a polymer-free drug-coated stent (DCS) was superior to ...
![ISAR-DESIRE 4 trial, TCT 2015, drug-coated balloon, DCB, scoring balloon, SCB, drug-eluting stent restenosis](/sites/default/files/styles/content_feed_large/public/field/image/X0000_Medtronic_IN.PACT%20Admiral%20Drug-Coated%20Balloon_Inflated%20In-Artery%20Illustration_0.jpg?itok=97QPWb_z)
October 22, 2015 — Results from the ISAR-DESIRE 4 trial indicate that use of a scoring balloon plus a paclitaxel-coated ...
![Amaranth Fortitute Bioresorbable stent](/sites/default/files/styles/content_feed_large/public/field/image/X0000_Amaranth_Fortitute_Bioresorbable_stent_scaffold.jpg?itok=AaU5PxUC)
There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT) annual ...
October 16, 2015 — Enrollment has successfully concluded in its multi-center, international CE mark clinical trials MEND ...
![ABSORB III trial, TCT 2015, bioresorbable vascular scaffold, BVS](/sites/default/files/styles/content_feed_large/public/field/image/Bioresorbable%20stent_Abbott_Absorb%20stent%20held%20by%20fingers_1.jpg?itok=VjbZUvpz)
October 16, 2015 — Results from a clinical trial showed that Abbott's Absorb everolimus-eluting bioresorbable vascular ...
October 15, 2015 — Two new advances in stent technology announced in recent days further reinforce the effectiveness of ...
October 15, 2015 — Biotronik has announced results from the BIOSOLVE-II trial, investigating the safety and clinical ...
October 14, 2015 — Tryton Medical Inc. announced results from the pivotal Tryton Confirmatory Study confirming the ...
October 5, 2015 — The U.S. Food and Drug Administration (FDA) has approved Boston Scientific’s Synergy Bioabsorbable ...
October 2, 2015 — Tryton Medical Inc. announced that results of a post hoc analysis of the pivotal Tryton Randomized ...
October 1, 2015 — Kimihiko Kichikawa, M.D., department of radiology at Nara Medical University in Japan, reported two ...
October 1, 2015 — Stentys announced that the company’s drug-eluting stent received CE Mark for treatment of below-the ...